Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Increased MT2-MMP expression in gastric cancer patients is associated with poor prognosis
Xiaoli Xu1, Lujun Chen1, Bin Xu1
1Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University Jiangsu Changzhou 213003, China.
Abstract:
Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that contribute to tumorigenesis and metastasis due to their ability to degrade the extracellular matrix (ECM) and basement membrane. In despite of many reports in other solid tumors, the role of membrane type-2 MMP (MT2-MMP) in gastric cancer (GC) remains to be elucidated. The aim of this study was to investigate MT2-MMP expression in human GC tissue microarray (TMA) samples using immunohistochemistry (IHC). We found that MT2-MMP expression in tumor tissues was significantly higher compared to peritumoral tissues (P < 0.01). However, there were no statistically significant differences between MT2-MMP expression and clinicopathological parameters. In addition, univariate and multivariate Cox regression analysis showed GC patients with high MT2-MMP expression have poor overall survival (OS) compared to patients with low MT2-MMP expression (P = 0.013, P = 0.040, respectively). In conclusion, MT2-MMP is involved in GC invasion and metastasis and may serve as an independent prognostic factor for GC patients.
Insights
Matrix metalloproteinase-2 (MT2-MMP) is elevated in gastric cancer (GC) tissues, correlating with poorer overall survival. This suggests MT2-MMP may be a prognostic marker for GC patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) facilitate tumor growth and spread by degrading the extracellular matrix.
- The specific role of membrane type-2 MMP (MT2-MMP) in gastric cancer (GC) is not well understood.
Purpose of the Study:
- To investigate MT2-MMP expression levels in human GC tissues.
- To determine the correlation between MT2-MMP expression and patient prognosis.
Main Methods:
- Immunohistochemistry (IHC) was used to analyze MT2-MMP expression in gastric cancer tissue microarrays (TMAs).
- Statistical analyses, including Cox regression, were performed to assess survival outcomes.
Main Results:
- MT2-MMP expression was significantly higher in GC tumor tissues compared to adjacent peritumoral tissues (P < 0.01).
- Elevated MT2-MMP expression was associated with significantly poorer overall survival (OS) in GC patients (P = 0.013 univariate, P = 0.040 multivariate).
- No significant association was found between MT2-MMP levels and other clinicopathological parameters.
Conclusions:
- MT2-MMP is implicated in gastric cancer invasion and metastasis.
- MT2-MMP may serve as an independent prognostic biomarker for predicting overall survival in gastric cancer patients.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Tumor Microenvironment

